Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360152 · ClinicalTrials.gov registry record · Early Phase 1
Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes
A Early Phase 1 study of Breast Neoplasms, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT00360152: Completed Early Phase 1 study of Breast Neoplasms, sponsored by Washington University School of Medicine.
NCT00360152 is a Early Phase 1 study of Breast Neoplasms that has completed, run by Washington University School of Medicine. The registered enrollment target is 100 participants, below the 568-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00360152, a Early Phase 1 study of Breast Neoplasms, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Sentinel lymph node biopsy (SLNB) has recently emerged as a less invasive alternative to axillary lymph node dissection (ALND) in the treatment of breast cancer. However, SLNB has a number of limitations, and we believe that alternative strategies for staging of the axilla should be explored. The hypothesis of this proposal is that the combination of preoperative high-resolution axillary ultrasound (AUS), fine needle aspiration biopsy (FNAB), and molecular analysis using real-time reverse transcription-polymerase chain reaction (RT-PCR) represents a viable, minimally invasive alternative to SLNB. We propose a prospective cohort study to rigorously assess the diagnostic accuracy of molecular analysis of AUS-FNAB specimens. The primary endpoint of this study is to determine the feasibility of AUS-FNAB and real-time RT-PCR to predict the pathologic status of the axilla in a proof-of-principle study. In the short term, validation of this innovative strategy is likely to reduce the number of sentinel node procedures. In the long term, we believe that AUS-FNAB may ultimately replace SLNB.
Conditions Studied
Interventions
- PROCEDURE Sentinel Lymph Node Biopsy
- PROCEDURE Fine needle aspiration biopsy (FNAB)
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-08 |
| Est. Completion | 2013-04 |
| Phase | Early Phase 1 |
What the finished NCT00360152 record still lists
NCT00360152 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 568-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Breast Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Sentinel Lymph Node Biopsy is the first listed.
NCT00360152 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00360152 about?
NCT00360152 is a clinical study titled "Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes". Sentinel lymph node biopsy (SLNB) has recently emerged as a less invasive alternative to axillary lymph node dissection (ALND) in the treatment of breast cancer. However, SLNB has a number of limitations, and we believe that alternative strategies for staging of the axilla should be explored. The hy...
What is the current status of trial NCT00360152?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2006-08. Estimated completion is 2013-04.
What conditions does trial NCT00360152 study?
This clinical trial studies the following conditions: Breast Neoplasms.
What interventions are being tested in trial NCT00360152?
The interventions under investigation include: Sentinel Lymph Node Biopsy (PROCEDURE), Fine needle aspiration biopsy (FNAB) (PROCEDURE).
Who is sponsoring clinical trial NCT00360152?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00360152 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00360152's enrollment target sits among peer trials
100 55th of 97 higher than 40 of 97 other Breast Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using Hyperpolarized [1-13C]Pyruvate to Detect Cardiotoxicity
COMPLETED · Early Phase 1
-
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
RECRUITING · Phase 2
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Registry Study of Breast Microseed Treatment
RECRUITING
-
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RECRUITING · Phase 1
-
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia